Currently, there appears to be little justification for complete sequencing of moderate penetrance genes, such as those of ATM, BRIP1, CHEK2, PALB2, and RAD50 in BRCA1/BRCA2-negative high-risk breast cancer families. This evidence concerns the gene BRCA1 and breast cancer.